Condition

Gastric and Gastroesophageal Junction Carcinoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Intervention

atezolizumab (1)

capecitabine (1)

oxaliplatin (1)

tiragolumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

gastric and gastroesophageal junction carcinoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Gastric and Gastroesophageal Junction Carcinoma Trial in China (Atezolizumab, Capecitabine, Oxaliplatin)

Recruiting

Gastric and Gastroesophageal Junction Carcinoma

Atezolizumab
+3 more

Beijing City, China
+11 more

Jul 29, 2022